$EXPD

Expeditors International Of Washington Q2 Earnings Rise

Expeditors International of Washington (EXPD) reported Q2 earnings of $266.2 million, or $2.03 per share, up from $183.6 million, or $1.34 per share, a year earlier. Revenue increased 32% to $3.502 billion from $2.651 billion. The company said results reflected double-digit growth across most products. EXPD last traded at $171.89 on the NYSE.

Original reporting
Published Aug 4, 2026, 2:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 3:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Expeditors International Of Washington Q2 Earnings Rise — source image
Decision brief

The 30-second read

$EXPDBullishMed
01

Why it matters

Traders can reassess near-term expectations based on the reported earnings and revenue growth, but the excerpt lacks forward guidance and profitability metrics.

02

Market read

A straightforward earnings and revenue beat-style update with a same-day positive tape, but without guidance details in the provided text.

03

What to watch

The article omits guidance, operating margin, backlog, and cash flow, which are typically key for post-earnings repricing.

Relevance 7/10Novelty 7/10Timing: reported Q2 results today, with stock trading around $171.89

Background

The company announced its second-quarter financial results and highlighted operational-excellence execution.

Company-level read

Ticker impact

$EXPDBullishMedium confidence
Context

Expeditors reported Q2 earnings of $2.03 per share and revenue up 32% to $3.502B, alongside a same-day stock move to $171.89.

Expected impact

Likely modest positive follow-through if investors view the growth as sustainable; otherwise, focus shifts to guidance not provided here.

Evidence & confidence

The article provides concrete earnings and revenue figures plus CEO commentary, but no guidance or margin detail to gauge durability or upside beyond the quarter.

Market effects

Supports the freight forwarding/logistics demand narrative if growth reflects broad-based volume rather than one-off factors.

No regional breakdown provided, so limited inference.

No global macro or trade-policy linkage provided beyond company performance.

Counterpoint

Strong revenue growth may not translate into sustained earnings power if costs, mix, or contract terms deteriorate, which is not assessed in the excerpt.

Key entities

  • Expeditors International of Washington, Inc.

    Reported Q2 earnings of $266.2M, or $2.03/share, and revenue up 32% to $3.502B.

  • Daniel Wall

    CEO who said the quarter demonstrated operational-excellence strategy and market-share gains.

Related articles

$EXPDMedAI 8/10

Expedition raises $115m Series B to advance COPD drug

Expedition raised $115m in a Series B to advance its COPD drug EXPD-101 through an ongoing Phase II trial (NCT07684820), and to expand its pipeline and discovery platform, according to CEO Yi Larson. EXPD-101 targets neutrophilic inflammation via DPP1 inhibition. The company cited prior Phase I results showing tolerability and once-daily oral dosing support.

$EXPDHigh

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD): Results of Operations and Financial Condition

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 expd-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 EARNINGS RELEASE By: Expeditors International of Washington, Inc. 3545 Factoria Blvd. SE Sterling Plaza 2, 3rd Floor Bellevue, Washington 98006 CONTACTS : Daniel R. Wall David A. Hackett Geoffrey Buscher President and Chief E

$EXPDMedAI 8/10

Strong quarter for Expeditors, air freight leads the way

Expeditors International reported Q2 results with airfreight volume up 14% year over year (13% April, 14% May, 15% June). Ocean freight was mixed, flat overall. Revenue rose 32% to $3.5B, operating income up 41% to $349.6M, and net income to $2.03 per share. CEO Daniel Wall cited strong air demand and tariff-driven customs activity.

$EXPDMedAI 8/10

Expeditors’s (NYSE:EXPD) Q2 CY2026: Strong Sales

Expeditors (NYSE:EXPD) reported Q2 CY2026 revenue of $3.50 billion, up 32.1% year on year and 18.6% above Wall Street estimates, and GAAP EPS of $2.03, 19.9% above consensus. The board declared a semi-annual dividend of $0.81 per share payable June 15, 2026. Analysts expect revenue growth of 1.1% over the next 12 months.

$ACHRMed

Anduril and Archer's autonomous VTOL platform, Expeditors' AOG expansion, and StandardAero's Arajet deal headline a busy day in aviation logistics

On July 20, 2026, Anduril and Archer Aviation (NYSE: ACHR) unveiled at Farnborough a dual-use autonomous VTOL platform, with a defense variant called Thunder, per Business Wire. Expeditors International (NYSE: EXPD) expanded its Aircraft on Ground coverage. StandardAero (NYSE: SARO) signed an LEAP-1B MRO deal with Arajet. Loganair signed a term sheet to buy BETA Technologies (NYSE: BETA) electric ALIA aircraft.

$CATMedAI 8/10

Critical Minerals: How Data Centres are Boosting Caterpillar

Caterpillar shares rose about 12% on 4 August after its Q2 results beat analyst expectations. The company reported revenue of $20.54bn, up 24% year on year, and adjusted EPS of $8.17 versus $6.20 expected. Operating profit was $4.3bn. Order backlog reached $72.1bn, up 92%, supporting construction and power demand tied to data centres.